Drugs for bad bugs: confronting the challenges of antibacterial discovery

作者: David J. Payne , Michael N. Gwynn , David J. Holmes , David L. Pompliano

DOI: 10.1038/NRD2201

关键词:

摘要: The sequencing of the first complete bacterial genome in 1995 heralded a new era of hope for antibacterial drug discoverers, who now had the tools to search entire genomes for new antibacterial targets. Several companies, including GlaxoSmithKline, moved back into the antibacterials area and embraced a genomics-derived, target-based approach to screen for new classes of drugs with novel modes of action. Here, we share our experience of evaluating more than 300 genes and 70 high-throughput screening campaigns over a …

参考文章(32)
B. P. Rosen, S. Mobashery, Resolving the antibiotic paradox: progress in understanding drug resistance and development of new antibiotics. Resolving the antibiotic paradox: progress in understanding drug resistance and development of new antibiotics.. ,(1998)
B Neal, W. Kaplan, R. Laing, Priority medicines for Europe and the world Priority Medicines for Europe and the World.. ,(2004)
Richard J. Heath, Charles O. Rock, A triclosan-resistant bacterial enzyme Nature. ,vol. 406, pp. 145- 146 ,(2000) , 10.1038/35018162
Pan F. Chan, David J. Holmes, David J. Payne, Finding the gems using genomic discovery: antibacterial drug discovery strategies – the successes and the challenges Drug Discovery Today: Therapeutic Strategies. ,vol. 1, pp. 519- 527 ,(2004) , 10.1016/J.DDSTR.2004.11.003
Wensheng Du, James R. Brown, Daniel R. Sylvester, Jianzhong Huang, Alison F. Chalker, Chi Y. So, David J. Holmes, David J. Payne, Nicola G. Wallis, Two Active Forms of UDP-N-Acetylglucosamine Enolpyruvyl Transferase in Gram-Positive Bacteria Journal of Bacteriology. ,vol. 182, pp. 4146- 4152 ,(2000) , 10.1128/JB.182.15.4146-4152.2000
Novel antibacterials: a genomics approach to drug discovery. Current Drug Targets - Infectious Disorders. ,vol. 2, pp. 291- 308 ,(2002) , 10.2174/1568005023342227
Magdalena Zalacain, Sanjoy Biswas, Karen A. Ingraham, Jennifer Ambrad, Alexander Bryant, Alison F. Chalker, Serban Iordanescu, Jing Fan, Frank Fan, R. Dwayne Lunsford, Karen O’Dwyer, Leslie M. Palmer, Chi So, Daniel Sylvester, Craig Volker, Patrick Warren, Damien McDevitt, James R. Brown, David J. Holmes, Martin K.R. Burnham, A global approach to identify novel broad-spectrum antibacterial targets among proteins of unknown function. Journal of Molecular Microbiology and Biotechnology. ,vol. 6, pp. 109- 126 ,(2003) , 10.1159/000076741
Frank Fan, Kang Yan, Nicola G. Wallis, Shannon Reed, Terrance D. Moore, Stephen F. Rittenhouse, Walter E. DeWolf, Jianzhong Huang, Damien McDevitt, William H. Miller, Mark A. Seefeld, Kenneth A. Newlander, Dalia R. Jakas, Martha S. Head, David J. Payne, Defining and Combating the Mechanisms of Triclosan Resistance in Clinical Isolates of Staphylococcus aureus Antimicrobial Agents and Chemotherapy. ,vol. 46, pp. 3343- 3347 ,(2002) , 10.1128/AAC.46.11.3343-3347.2002
Joseph A. DeVito, Jonathan A. Mills, Veronica G. Liu, Anjana Agarwal, Christine F. Sizemore, Zhongjie Yao, Daniel M. Stoughton, Maria Grazia Cappiello, Maria D.F.S. Barbosa, Lorie A. Foster, David L. Pompliano, An array of target-specific screening strains for antibacterial discovery Nature Biotechnology. ,vol. 20, pp. 478- 483 ,(2002) , 10.1038/NBT0502-478